Caldwell Sutter Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.71K Hold
7
﹤0.01% 767
2026
Q1
$2.05K Hold
7
﹤0.01% 752
2025
Q4
$2.45K Hold
7
﹤0.01% 718
2025
Q3
$2.26K Hold
7
﹤0.01% 729
2025
Q2
$2.72K Hold
7
﹤0.01% 684
2025
Q1
$3.04K Hold
7
﹤0.01% 684
2024
Q4
$2.58K Hold
7
﹤0.01% 717
2024
Q3
$3.64K Hold
7
﹤0.01% 687
2024
Q2
$3.79K Hold
7
﹤0.01% 669
2024
Q1
$3.63K Hold
7
﹤0.01% 666
2023
Q4
$3.3K Hold
7
﹤0.01% 686
2023
Q3
$3.05K Hold
7
﹤0.01% 668
2023
Q2
$3.11K Buy
+7
New +$3.23K ﹤0.01% 678

Other funds holding ELV

Caldwell Sutter Capital's ELV Position: Q2 2026 in Review

Caldwell Sutter Capital held its Elevance Health (ELV) position steady in Q2 2026 at 7 shares worth $2.71K. The position accounts for ﹤0.01% of the portfolio, ranked #767.

Caldwell Sutter Capital first reported a position in ELV in Q2 2023 and has held it in 13 quarters since. The position peaked at $3.79K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Caldwell Sutter Capital held 7 shares of Elevance Health worth $2.71K as of Q2 2026.
  • Caldwell Sutter Capital left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q2 2026, its #767 holding.
  • Caldwell Sutter Capital first reported a position in Elevance Health in Q2 2023 and has held it in 13 quarters since.
  • Caldwell Sutter Capital's Elevance Health position peaked at $3.79K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.